BRANFORD, Conn., July 28, 2011 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) today announced that it has achieved another key objective in its on-going transition by filling two key sales management positions. Frank P. Gregorio has been appointed the Director of North American Sales, and Ignacio J. Silva was named as the Director of International Business Development. Thomas M. Patton, President and CEO of CASMED, stated, "I am excited to welcome sales professionals of the caliber of Frank and Ignacio to CASMED. They bring vast experience in the medical device marketplace and will play vital roles as we continue to build and support our global sales team for our industry leading FORE-SIGHT® tissue oximetry technology and our Traditional Monitoring product lines. These hires mark one more milestone as we continue to invest in our growth initiatives."
Mr. Gregorio has over 22 years of sales and sales management experience in the medical device arena, including more than 14 years at Mindray Medical (formerly the Patient Monitoring Division of Datascope Corp.) including many years as Vice President, U.S. Sales Operations. Most recently, Mr. Gregorio was Clinical Sales Manager at Intuitive Surgical, Inc. Mr. Gregorio's experience includes development and management of both direct and distributor based sales channels. "Frank is an experienced executive who understands how to recruit, train, develop and support his sales team to achieve peak sales performance," said Matthew J. Herwig, CASMED's Vice President of Sales and Marketing. Prior to Mindray, Mr. Gregorio held sales and management positions with Devon Industries, Inc. and Allergan, Inc. He holds a Bachelor of Arts in Business Management from North Central College in Illinois.
As Director of International Business Development, Mr. Silva brings 20 years of global experience in medical device sales including deep experience in Europe, Africa and Asia. He is a keen global business manager and developer of new distribution channels. Most recently he was with Teleflex Medical OEM as Vice President of Global Sales, Marketing and Customer Care. "Ignacio's fluency in developing and growing markets outside the United States will be key to our continued penetration of FORE-SIGHT sales into new markets, and into new accounts within existing markets," Mr. Herwig added. Prior to Teleflex, Mr. Silva held senior international sales, marketing and business development positions at Smiths Medical PLC, Impra-C.R. Bard International and Vaso Products, Inc. He holds a Bachelor of Arts in Philosophy from Villanova University and an MBA in International Finance and Asian Studies from the Thunderbird School of Global Management.
"These two new hires bring an impressive array of sales talent to the CASMED organization," Mr. Herwig continued. "I look forward to working along side them to expand our business and meet our aggressive growth objectives."
About CASMED®- Monitoring What's Vital
CAS Medical Systems, Inc. is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT Absolute Tissue Oximeter is the only cerebral oximeter available with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for all patients – adult, pediatric and neonatal – regardless of age or weight. This information helps avert brain damage or death during surgery and in critical care situations by allowing clinicians to identify patients with dangerously low levels of cerebral oxygen and intervene to reverse the condition.
The Company's product lines include the high-acuity monitoring capabilities of the FORE-SIGHT Absolute Tissue Oximeter, and Traditional Vital Signs Monitoring, including bedside patient vital signs monitoring products, proprietary non-invasive blood pressure measurement technology, neonatal intensive care supplies, and service. CASMED products are designed to meet the needs of a full spectrum of patient populations worldwide, ranging from adults to pediatrics and neonates. For further information regarding CAS Medical Systems, Inc., visit the Company's website at www.casmed.com/" target="_top" rel="nofollow">www.casmed.com.
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, customer acceptance of the Company's products in the market, the introduction of competitive products and product development, the impact of any product liability or other adverse litigation, working capital and availability of capital, commercialization and technological difficulties, the impact of actions and events involving key customers, vendors, lenders and competitors and other risks detailed in the Company's Form 10-K for the year ended December 31, 2010 and other subsequent Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release, the terms "anticipate," "believe," "estimate," "expect," "may," "objective", "plan," "possible," "potential", "will" and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.